Scrip Regulatory Affairs
UK medtech investigation: regulators, industry and experts react
18 May 2011
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- UK PIP report highlights need to improve adverse incident reporting; registries urged
- EU medtech report calls for randomised clinical trials and centralised pre-market evaluation
- EU parliament resolution plan expected to call for device pre-market authorisation system
- Medtech trade bodies on PIP breast implants: crisis is a result of criminal action, not inadequacy of regulations
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
